Eike Floettmann

442 total citations
11 papers, 375 citations indexed

About

Eike Floettmann is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Eike Floettmann has authored 11 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 3 papers in Immunology. Recurrent topics in Eike Floettmann's work include Viral-associated cancers and disorders (3 papers), Gastrointestinal motility and disorders (2 papers) and Neuropeptides and Animal Physiology (2 papers). Eike Floettmann is often cited by papers focused on Viral-associated cancers and disorders (3 papers), Gastrointestinal motility and disorders (2 papers) and Neuropeptides and Animal Physiology (2 papers). Eike Floettmann collaborates with scholars based in United Kingdom, Sweden and United States. Eike Floettmann's co-authors include Martin Rowe, John Unitt, Alan B. Rickinson, Geraint J. C. Wilde, Michael White, Mark A. Oakley Browne, Stuart Prince, Khanh Bui, David G. Spiller and Paul Brennan and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Journal of Cell Science.

In The Last Decade

Eike Floettmann

11 papers receiving 371 citations

Peers

Countries citing papers authored by Eike Floettmann

Since Specialization

Citations

This map shows the geographic impact of Eike Floettmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eike Floettmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eike Floettmann more than expected).

Fields of papers citing papers by Eike Floettmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eike Floettmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eike Floettmann. The network helps show where Eike Floettmann may publish in the future.

Co-authorship network of co-authors of Eike Floettmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eike Floettmann. A scholar is included among the top collaborators of Eike Floettmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eike Floettmann. Eike Floettmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Naloxegol, an opioid antagonist with reduced CNS penetration: Mode-of-action and human relevance for rat testicular tumours 2017 ·Toxicology and Applied Pharmacology ·Håkan Andersson, (unknown), (unknown), Eike Floettmann	1
2	Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Eike Floettmann, Khanh Bui, Mark Sostek, Kemal Payza, Michael A. Eldon	37
3	Clinical Pharmacokinetics and Pharmacodynamics of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist 2016 ·Clinical Pharmacokinetics ·Khanh Bui, Diansong Zhou, Hongmei Xu, Eike Floettmann, Nidal Al‐Huniti	13
4	Pharmacological Inhibition of DGAT1 Induces Sebaceous Gland Atrophy in Mouse and Dog Skin While Overt Alopecia Is Restricted to the Mouse 2014 ·Toxicologic Pathology ·Eike Floettmann, David Eric Lees, Frank Seeliger, Huw B. Jones	5
5	Prolonged Inhibition of Glycogen Phosphorylase in Livers of Zucker Diabetic Fatty Rats Models Human Glycogen Storage Diseases 2010 ·Toxicologic Pathology ·Eike Floettmann, (unknown), (unknown), (unknown), (unknown), Simon M. Poucher, Huw B. Jones	16
6	Imaging Kidney in Conscious Rats with High-Frequency Ultrasound and Detection of Two Cases of Unilateral Congenital Hydronephrosis 2007 ·Ultrasound in Medicine & Biology ·Yì Wáng, Graham R. Betton, Eike Floettmann, (unknown), (unknown)	15
7	Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Andrew Baxter, (unknown), Anne Cooper, Eike Floettmann, (unknown), (unknown), Jason G. Kettle, Tom McInally, Craig A. Martin, (unknown), M. Needham, Pete Newham, Stuart W. Paine, Stephen A. St-Gallay, (unknown), John Unitt, Yafeng Xue	70
8	Latent Membrane Protein 1 Inhibits Epstein-Barr Virus Lytic Cycle Induction and Progress via Different Mechanisms 2003 ·Journal of Virology ·Stuart Prince, Sinéad E. Keating, Ceri A. Fielding, Paul Brennan, Eike Floettmann, Martin Rowe	57
9	Multi-parameter analysis of the kinetics of NF-κB signalling and transcription in single living cells 2002 ·Journal of Cell Science ·Glyn Nelson, Luminita Paraoan, David G. Spiller, Geraint J. C. Wilde, Mark A. Oakley Browne, (unknown), John Unitt, Elaine Sullivan, Eike Floettmann, Michael White	96
10	Differential Responses to CD40 Ligation Among Burkitt Lymphoma Lines That Are Uniformly Responsive to Epstein-Barr Virus Latent Membrane Protein 1 1999 ·The Journal of Immunology ·Nico V. Henriquez, Eike Floettmann, Mike Salmon, Martin Rowe, Alan B. Rickinson	45
11	A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro 1996 ·Journal of Virology ·Suzanne M. Morgan, Gavin W. G. Wilkinson, Eike Floettmann, (unknown), Alan B. Rickinson	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact